NCT02378649View on ClinicalTrials.gov

PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Pulmonary HypertensionMitral Valve Surgery
Interventions
DRUG

Sildenafil

Sildenafil administration in the cardiac ICU following Mitral Valve Surgery concomitant with best practice usual care

DRUG

Placebo

Placebo comparator concomitant with best practice usual care

Trial Locations (1)

52621

Cardiac Surgical Department, Leviev Heart Center, Ramat Gan

All Listed Sponsors
lead

Dr. Robert Klempfner Heart Rehabilitation Institute

OTHER_GOV

NCT02378649 - PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertension | Biotech Hunter | Biotech Hunter